细胞毒性T细胞
颗粒酶B
生物
CD8型
免疫学
白细胞介素21
颗粒酶
穿孔素
CD28
颗粒酶A
T细胞
免疫系统
体外
生物化学
作者
J A Seidel,Milica Vukmanovic‐Stejic,Bojana Müller-Durovic,Neil P Patel,Judilyn Fuentes‐Duculan,Siân M. Henson,James G. Krueger,Malcom H. A. Rustin,Frank Oliver Nestle,Katie E. Lacy,Arne N. Akbar
摘要
Summary The in-depth understanding of skin resident memory CD8+ T lymphocytes (TRM) may help to uncover strategies for their manipulation during disease. We investigated isolated TRM from healthy human skin, which expressed the residence marker CD69, and compared them to circulating CD8+ T cell populations from the same donors. There were significantly increased proportions of CD8+CD45RA−CD27− T cells in the skin that expressed low levels of killer cell lectin-like receptor G1 (KLRG1), CD57, perforin and granzyme B. The CD8+ TRM in skin were therefore phenotypically distinct from circulating CD8+CD45RA−CD27− T cells that expressed high levels of all these molecules. Nevertheless, the activation of CD8+ TRM with T cell receptor (TCR)/CD28 or interleukin (IL)-2 or IL-15 in vitro induced the expression of granzyme B. Blocking signalling through the inhibitory receptor programmed cell death 1 (PD)-1 further boosted granzyme B expression. A unique feature of some CD8+ TRM cells was their ability to secrete high levels of tumour necrosis factor (TNF)-α and IL-2, a cytokine combination that was not seen frequently in circulating CD8+ T cells. The cutaneous CD8+ TRM are therefore diverse, and appear to be phenotypically and functionally distinct from circulating cells. Indeed, the surface receptors used to distinguish differentiation stages of blood T cells cannot be applied to T cells in the skin. Furthermore, the function of cutaneous TRM appears to be stringently controlled by environmental signals in situ.
科研通智能强力驱动
Strongly Powered by AbleSci AI